Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Secondary
1.7.1.1 Paid sources
1.7.1.2 Unpaid sources
1.7.2 Primary
Chapter 2 Executive Summary
2.1 Sepsis diagnostics market industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Technology trends
2.1.5 Method type trends
2.1.6 Pathogen type trends
2.1.7 End-use trends
Chapter 3 Sepsis Diagnostics Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Surge in prevalence of infectious diseases
3.3.1.2 Increasing government initiatives towards infectious diseases
3.3.1.3 Technological advancements in infectious diseases diagnosis
3.3.1.4 Rising awareness regarding infectious diseases and its diagnosis
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of diagnostic devices
3.3.2.2 Stringent regulatory framework
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By technology
3.4.3 By method type
3.4.4 By pathogen type
3.4.5 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive dashboard
4.4 Company market share, 2021
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Sepsis Diagnostics Market and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Instruments
5.3 Assay kits & reagents
5.4 Blood culture media
5.5 Software
Chapter 6 Sepsis Diagnostics Market and Forecast, By Technology (USD Million)
6.1 Key trends, by technology
6.2 Microbiology
6.3 Molecular diagnostics
6.4 Immunoassays
6.5 Flow cytometry
Chapter 7 Sepsis Diagnostics Market and Forecast, By Method Type (USD Million)
7.1 Key trends, by method type
7.2 Conventional diagnostics
7.3 Automated diagnostics
Chapter 8 Sepsis Diagnostics Market and Forecast, By Pathogen Type (USD Million)
8.1 Key trends, by pathogen type
8.2 Bacterial sepsis
8.3 Fungal sepsis
8.4 Others
Chapter 9 Sepsis Diagnostics Market and Forecast, By End-use (USD Million)
9.1 Key trends, by end-use
9.2 Hospitals
9.3 Diagnostic centers
9.4 Clinics
9.5 Others
Chapter 10 Sepsis Diagnostics Market and Forecast, By Region (USD Million)
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Russia
10.3.7 Poland
10.3.8 Switzerland
10.3.9 Norway
10.3.10 Finland
10.3.11 Sweden
10.3.12 Denmark
10.3.13 The Netherlands
10.4 Asia Pacific
10,41 China
10.4,2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Taiwan
10.4.7 Indonesia
10.4.8 Vietnam
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Colombia
10.5.5 Chile
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Israel
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 BioMerieux SA
11.3 Thermo Fisher Scientific Inc.
11.4 Becton, Dickinson and Company
11.5 Bruker Corporation
11.6 Beckman Coulter, Inc.
11.7 T2 Biosystems, Inc.
11.8 Nanosphere, Inc.
11.9 Hoffmann-LA Roche Ltd.
11.10 Danaher Corporation
